Evidence based pathology: Squamous carcinoma of the hypopharynx

Journal of Clinical Pathology

Volumn 56, Issue 2, 2003, Pages 81-85

  Helliwell, T R ^a  

^a Department of Pathology ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; ENDOTHELIAL CELL GROWTH FACTOR; MOLECULAR MARKER; PROTEIN P53;

ADVANCED CANCER; BASAL CELL CARCINOMA; BIBLIOGRAPHIC DATABASE; CANCER CLASSIFICATION; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CHROMOSOME ABERRATION; CLINICAL PRACTICE; COMPARATIVE STUDY; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; GEOGRAPHIC DISTRIBUTION; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HYPOPHARYNX CARCINOMA; INCIDENCE; INFORMATION; LYMPH NODE METASTASIS; MEDICAL LITERATURE; MEDLINE; METASTASIS; NOMENCLATURE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURGICAL ANATOMY; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR VOLUME; UNDIFFERENTIATED CARCINOMA; AGED; HYPOPHARYNX TUMOR; MIDDLE AGED; PATHOLOGY;

AGED; CARCINOMA, SQUAMOUS CELL; EVIDENCE-BASED MEDICINE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 0037316245     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.2.81     Document Type: Review

References (52)

1. Pameijer FA, Mukherji SK, Balm AJM, et al. Imaging of squamous cell carcinoma of the hypopharynx. Semin Ultrasound CT MR 1998;19:476-91.
2. Bradley PJ. Survey of current management of laryngeal and hypopharyngeal cancer. J R Coll Surg Edinb 1989;34:197-200.
3. Kleinsasser O. Tumours of the larynx and hypopharynx. Stuttgart: Georg Thieme, 1988.
4. Berrino F, Gatta G, Group EW. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. Eur J Cancer 1998;34:2154-61.
5. Harrison DFN. Pathology of hypopharyngeal cancer in relation to surgical management. J Laryngol Otol 1970;84:349-67.
6. Barnes L, Johnson J. Pathologic and clinical considerations in the evaluation of major head and neck specimens resected for cancer. Pathol Annu 1986;21:173-250.
7. Michaels L Squamous carcinoma of the hypopharynx. In: Ear nose and throat histopathology. London: Springer-Verlag, 1987:459-63.
8. Harrison DFN. Malignant disease of the hypopharynx: surgical pathology of hypopharyngeal neoplasms. J Laryngol Otol 1971;85:1215-18.
9. Olofsson J, van Nostrand AW. Growth and spread of laryngeal and hypopharyngeal carcinoma with reflections on the effect or preoperative irradiation. 139 cases studied by whole organ sectioning. Acta Otolaryngol (Stockh) 1973;308(suppl):1-84.
10. Kirchner JA. Pyriform sinus cancer: a clinical and laboratory study. Ann Otol Rhinol Laryngol 1975;84:793-804.
11. Kirchner JA, Owen J. Five hundred cancers of the larynx and pyriform sinus. Laryngoscope 1977;87:1288-303.
12. Spector JG, Sessions DG, Emami B, et al. Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long term results. Laryngoscope 1995;105:397-406.
13. Jones AS, Stell PM. Squamous carcinoma of the posterior pharyngeal wall. Clin Ototaryngo 1991;16:462-5.
14. Willatt DJ, Jackson SR, McCormick MS, et al. Vocal cord paralysis and tumour lengths in staging postcricoid cancer. Eur J Surg Oncol 1987;13:131-7.
15. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol 1995;79:321-9.
16. Hellquist H, Lundgren J, Olofsson J. Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords-a follow-up study. Clin Otolaryngol 1982;7:11-27.
17. Roland NJ, Caslin AW, Nash J, et al. Value of grading squamous cell carcinoma of the head and neck. Head Neck 1992;14:224-9.
18. Bryne M, Boysen M, Alfsen CG, et al. The invasive front of carcinomas. The most important area for tumour prognosis? Anticancer Res 1998;18:4757-64.
19. Raslan WF, Barnes L, Krause JR, et al. Basaloid squamous cell carcinoma of the head and neck: a clinicopathologic and flow cytometric study of 10 new cases with review of the English literature. Am J Otolaryngol 1994;15:204-11.
20. Dray T, Vargas H, Weidner N, et al. Lymphoepitheliomas of the laryngohypopharynx. Am J Otolaryngol 1998;19:263-6.
21. Magnano M, Bongioannini G, Lerda W, et al. Lymph node metastasis in head and neck squamous cells carcinoma: multivariate analysis of prognostic variables. J Exp Clin Cancer Res 1999;18:79-83.
22. Spector JG Sessions DG, Haughey BH, et al. Delayed regional metastasis, distant metastases and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 2001;111:1079-87.
23. Byers RM, Wolf PF, Ballantyne AJ. Rationale for elective modified neck dissection. Head Neck 1988;10:160-7.
24. Jones AS, Phillips DE, Helliwell TR, et al. Occult node metastases in head and neck squamous carcinoma. Eur Arch Otorhinolaryngol 1993;250:446-9.
25. Buckley JG, Maclennan K. Cervical node metastases in laryngeal and hypopharyngeal cancer: a prospective analysis of prevalence and distribution. Head Neck 2000;22:380-5.
26. Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper digestive tract. Am J Surg 1990;160:405-9.
27. Jones AS, Roland NJ, Field JK, et al. The level of cervical lymph node metastases: their prognostic relevance and relationship with head and neck squamous carcinoma primary sites. Clin Otolaryngol 1994;19:63-9.
28. Candela FC, Hothari K, Shah JP. Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head Neck 1990;12:197-203.
29. Ballantyne AJ. Significance of retropharyngeal nodes in cancer of the head and neck. Am J Surg 1964;108:500-4.
30. de Carvalho MB. Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinama of the larynx and hypopharynx. Head Neck 1998;20:16-21.
31. Barnes L, Gnepp DR. Diseases of the larynx, hypopharynx and esophagus. In: Barnes L, ed. Surgical pathology of the head and neck. New York: Decker, 1985:293-315.
32. Merino OR, Lindberg RD, Fletcher GH. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1977;40:145-51.
33. Jones AS, Morar P, Phillips DE, et al. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995;75:1343-53.
34. Smith BD, Haffty BG. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous carcinomas. Radiat Oncol Investig 1999;7:125-44.
35. Jefferies S, Foulkes WD. Genetic mechanisms in squamous cell carcinoma of the head and neck. Oral Oncol 2001;37:115-26.
36. Del Valle-Zapico A, Fernandez FF, Suarez AR, et al. Prognostic value of histopathologic parameters and DNA flow cytometry in squamous cell carcinoma of the pyrifarm sinus. Laryngoscope 1998;108:269-72.
37. Gaffey MJ, lezzoni JC, Meredith SD, et al. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase gene expression in head and neck squamous cell carcinoma. Hum Pathol 1995;26:1221-6.
38. Takes RP, Baatenburg de Jong RJ, Schuuring E, et al. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell carcinoma. Anticancer Res 1998;18:4793-800.
39. Guerry M, Vabre L, Talbot M, et al. Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma: a case-control study. Br J Cancer 1998;77:1932-6.
40. Pukkila MJ, Virtaniemi JA, Kumpulainen EJ, et al. Nuclear B-catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma. J Clin Pathol 2001;54:42-7.
41. Poetsch M, Kleist B, Lorenz G, et al. Different numerical chromosomal aberrations detected by FISH in oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma. Histopathology 1999;34:234-40.
42. Sobin LH, Wittekind C. TNM classification of malignant tumours, 5th ed. New York: John Wiley & Sons, 1997.
43. Jones AS. Tumours of the hypopharynx. In: Jones AS, Phillips DE, Hilgers FJM, eds. Diseases of the head and neck, nose and throat. London: Edward Arnold; 1998:230-49.
44. Jakobsen J, Hansen O, Jorgensen KE, et al. Lymph node metastases from laryngeal and pharyngeal carcinomas-calculation of burden of metastasis and its impact on prognosis. Acta Oncol 1998;37:489-93.
45. Batsakis JG. Surgical excision margins: a pathologist's perspective. Adv Anat Pathol 1999;6:140-8.
46. Beaumont DG, Hains JD Changes in surgical margins in vivo following resection and after fixation. Aust J Otolaryngol 1992;1:51-2.
47. Looser KG, Shah JP, Strong EW. The significance of "positive" margins in surgically resected epidermoid carcinomas. Head Neck 1978;1:107-11.
48. Gath HJ, Brakenhoff RH. Minimal residual disease in head and neck cancer. Cancer Metastasis Rev 1999;18:109-26.
49. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995 332:429-35.
50. Franklin S, Pho T Abreo FW, et al. Detection of the proto-oncogene elF 4E in larynx and hypopharynx cancers. Arch Otolaryngol 1999;125:177-82.
51. Chiesa F Tradati N Mauri S, et al. Prognostic factors in head and neck oncology: a critical appraisa for use in clinical practice. Anticancer Res 1998;18:4769-76.
52. Helliwell TR Woolgar JA. Minimum dataset for the reporting of head and neck carcinomas. London: The Royal College of Pathologists, 1998.